Darzalex is a biologic medicine containing Daratumumab, used in the treatment of multiple myeloma. It is a targeted therapy that works by identifying and attacking cancerous plasma cells, helping to slow disease progression.
Indications
-
Treatment of multiple myeloma
-
Used as part of targeted therapy or chemotherapy regimens
-
Helps reduce cancer cell growth
-
Supports disease control
Directions for Use
Administered by subcutaneous injection or intravenous infusion in a hospital or clinical setting under specialist supervision.
Warnings
-
Prescription medicine – use under medical supervision
-
May cause infusion or injection-related reactions
-
May increase risk of infections
-
Regular medical monitoring is required
-
Keep out of reach of children
Reviews
There are no reviews yet.